Mechanistic insights into the dual inhibition strategy for checking Leishmaniasis

Leishmaniasis 1 1 These authors contributed equally. is an endemic disease mainly caused by the protozoan Leishmania donovani (Ld). Polyamines have been identified as essential organic compounds for the growth and survival of Ld. These are synthesized in Ld by polyamine synthesis pathway comprising...

Full description

Saved in:
Bibliographic Details
Published in:Journal of biomolecular structure & dynamics Vol. 30; no. 4; pp. 474 - 487
Main Authors: Grover, Abhinav, Katiyar, Shashank Prakash, Jeyakanthan, Jeyaraman, Dubey, Vikash Kumar, Sundar, Durai
Format: Journal Article
Language:English
Published: England Routledge 01-01-2012
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Leishmaniasis 1 1 These authors contributed equally. is an endemic disease mainly caused by the protozoan Leishmania donovani (Ld). Polyamines have been identified as essential organic compounds for the growth and survival of Ld. These are synthesized in Ld by polyamine synthesis pathway comprising of many enzymes such as ornithine decarboxylase (ODC), spermidine synthase (SS), and S-adenosylmethionine decarboxylase. Inhibition of these enzymes in Ld offers a viable prospect to check its growth and development. In the present work, we used computational approaches to search natural inhibitors against ODC and SS enzymes. We predicted three-dimensional structures of ODC and SS using comparative modeling and molecular dynamics (MD) simulations. Thousands of natural compounds were virtually screened against target proteins using high throughput approach. MD simulations were then performed to examine molecular interactions between the screened compounds and functional residues of the active sites of the enzymes. Herein, we report two natural compounds of dual inhibitory nature active against the two crucial enzymes of polyamine pathway of Ld. These dual inhibitors have the potential to evolve as lead molecules in the development of antileishmanial drugs.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0739-1102
1538-0254
DOI:10.1080/07391102.2012.682212